1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Bayer Pays Over $110 Million to Settle Yaz Birth Control Cases

Ennis & Ennis, P.A. Explains the Recent Yaz/Yasmin Birth Control Settlement

FOR IMMEDIATE RELEASE

 
 
yaz
yaz
PRLog (Press Release) - Apr. 13, 2012 - Bayer will pay at least $110 million to settle about 500 lawsuits wherein plaintiffs allege that Yaz/Yasmin birth control pills caused serious injuries of which Bayer knew, or should have known, and failed to warn, reports Bloomberg.  Bayer officials agreed to pay an average of about $220,000 a case to resolve claims in involving fatal blood clots that can lead to heart attacks and stroke.

In January 2012, the Honorable David Herndon, who is the presiding judge on many Bayer birth control pill lawsuits, postponed the first scheduled Yaz trial and ordered the case to mediation.  (http://www.ilsd.uscourts.gov/Documents/mdl2100/Order53.pdf).

In February 2012, Bayer Healthcare reported that it settled approximately 70 YAZ/Yasmin claims.  “This is yet another step in the right direction.  Clearly this court ordered mediation started the process for a potential global resolution to the litigation,” commented attorney Holly Ennis of Ennis & Ennis, P.A.

The notice of the settlements comes days after the U.S. Food and Drug Administration (FDA) announced a label change for drospirenone-containing birth control pills, such as Yaz and Yasmin, to include the increased risk for developing dangerous blood clots.  

The revised label addresses studies that reported a three-fold increase in the risk of blood clots for drospirenone-containing birth control pills when compared to “older generation” birth control pills containing levonorgestrel or some other progestins.

The FDA’s label change decision follows the recommendation of an advisory panel that met in December, voting 21-5 that labeling on Bayer’s Yaz birth control pill is inadequate and should be revised to better reflect the higher risk of blood clots associated with these drugs.

Ennis & Ennis P.A. continues to offer free, nationwide, confidential consultations for women who have suffered Yaz and Yasmin side effects by calling toll free 1-800-856-6405 or by going to www.ennislaw.com and completing an online case evaluation form.

Ennis & Ennis, P.A. is a nationwide law firm with offices in Ft. Lauderdale, Miami and Washington D.C. that concentrates its practice in mass torts and represents individuals against pharmaceutical companies and medical device makers.

Ennis & Ennis, P.A. has been representing clients individually since 1986 and has recovered over $100 million in settlements for its clients.

Ennis & Ennis, P.A. is also investigating cases involving Accutane, Actos, Avandia, Fosamax, Pradaxa, Plavix, Paxil/birth defect, Zoloft/birth defect, Prozac, Multaq, Depuy Hip Recall, Wright Conserve Hip Devices, Wright Profemur Hip Devices, Zimmer Hip Recall, all Metal-on-Metal Hip Implants, Depakote, Reglan, SJS/Dilantin, Yaz, Yasmin, Ocella Birth Control Pills, and Transvaginal Mesh Devices.

Remember the law limits the time in which you can file a claim, so don't wait to explore your legal rights.  Call today toll free 1-800-856-6405 or visit www.ennislaw.com.

Photo:
http://www.prlog.org/11848923/1

--- End ---

Click to Share

Contact Email:
***@ennislaw.com Email Verified
Source:Jami Angelini Haggerty
Phone:800-856-6405
Address:110 E. Broward Blvd., Suite 1700
Zip:33301
City/Town:Fort Lauderdale - Florida - United States
Industry:Health, Legal
Tags:, , yaz birth control, , , ,
Shortcut:http://prlog.org/11848923
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Upcoming Press Releases...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
8.4K1.9K2.6K
Click to Share